SG11201507103YA - MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA - Google Patents
MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMAInfo
- Publication number
- SG11201507103YA SG11201507103YA SG11201507103YA SG11201507103YA SG11201507103YA SG 11201507103Y A SG11201507103Y A SG 11201507103YA SG 11201507103Y A SG11201507103Y A SG 11201507103YA SG 11201507103Y A SG11201507103Y A SG 11201507103YA SG 11201507103Y A SG11201507103Y A SG 11201507103YA
- Authority
- SG
- Singapore
- Prior art keywords
- microrna
- based approach
- malignant pleural
- treating malignant
- pleural mesothelioma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/801,010 US9006200B2 (en) | 2013-03-13 | 2013-03-13 | MicroRNA-based approach to treating malignant pleural mesothelioma |
| PCT/IB2014/000723 WO2014140797A1 (en) | 2013-03-13 | 2014-03-12 | MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507103YA true SG11201507103YA (en) | 2015-10-29 |
Family
ID=51530004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507103YA SG11201507103YA (en) | 2013-03-13 | 2014-03-12 | MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9006200B2 (en) |
| EP (1) | EP2968604B1 (en) |
| JP (1) | JP6437930B2 (en) |
| KR (1) | KR102099718B1 (en) |
| CN (1) | CN105283205B (en) |
| AU (1) | AU2014229648B2 (en) |
| CA (1) | CA2905682C (en) |
| ES (1) | ES2664759T3 (en) |
| IL (1) | IL241300B (en) |
| SG (1) | SG11201507103YA (en) |
| WO (1) | WO2014140797A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018157026A1 (en) | 2017-02-26 | 2018-08-30 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Treatment of tumors with mirna targeting cdk4/cdk6 |
| CN108421038A (en) * | 2017-04-19 | 2018-08-21 | 范兴龙 | A method of treat malignant pleural mesothelioma based on microRNA |
| CA3107095A1 (en) * | 2018-07-23 | 2020-01-30 | Engeneic Molecular Delivery Pty Ltd | Compositions comprising bacterially derived minicells and methods of using the same |
| IT202100008798A1 (en) | 2021-04-08 | 2022-10-08 | Univ Degli Studi Di Ferrara | USE OF MICRORNA HSA-MIR-197-3P AS A MARKER OF ASBESTOS EXPOSURE AND MALIGNANT MESOTHELIOMA OF THE PLEURAL |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4965447B2 (en) | 2004-08-26 | 2012-07-04 | エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド | Delivery of functional nucleic acids to mammalian cells via intact minicells from bacteria |
| EP2281888B1 (en) * | 2004-11-12 | 2015-01-07 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
| EP2145001A2 (en) | 2006-09-19 | 2010-01-20 | Asuragen, Inc. | Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
| WO2009027830A2 (en) * | 2007-03-30 | 2009-03-05 | Engeneic Molecular Delivery Pty Ltd. | Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| CN101849008A (en) * | 2007-09-19 | 2010-09-29 | 应用生物系统有限公司 | SiRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof |
| US8188060B2 (en) | 2008-02-11 | 2012-05-29 | Dharmacon, Inc. | Duplex oligonucleotides with enhanced functionality in gene regulation |
| US9157080B2 (en) | 2009-09-09 | 2015-10-13 | New York University | Compositions and methods for treatment, diagnosis and prognosis of mesothelioma |
-
2013
- 2013-03-13 US US13/801,010 patent/US9006200B2/en active Active
-
2014
- 2014-03-12 CN CN201480014962.0A patent/CN105283205B/en active Active
- 2014-03-12 ES ES14762791.3T patent/ES2664759T3/en active Active
- 2014-03-12 EP EP14762791.3A patent/EP2968604B1/en active Active
- 2014-03-12 CA CA2905682A patent/CA2905682C/en active Active
- 2014-03-12 WO PCT/IB2014/000723 patent/WO2014140797A1/en active Application Filing
- 2014-03-12 SG SG11201507103YA patent/SG11201507103YA/en unknown
- 2014-03-12 AU AU2014229648A patent/AU2014229648B2/en active Active
- 2014-03-12 JP JP2015562371A patent/JP6437930B2/en active Active
- 2014-03-12 KR KR1020157028356A patent/KR102099718B1/en active IP Right Grant
-
2015
- 2015-04-10 US US14/684,106 patent/US9220724B2/en active Active
- 2015-09-08 IL IL241300A patent/IL241300B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US9220724B2 (en) | 2015-12-29 |
| CA2905682C (en) | 2021-09-14 |
| AU2014229648B2 (en) | 2018-08-09 |
| KR20150130444A (en) | 2015-11-23 |
| CN105283205B (en) | 2019-12-20 |
| KR102099718B1 (en) | 2020-04-14 |
| CA2905682A1 (en) | 2014-09-18 |
| IL241300A0 (en) | 2015-11-30 |
| EP2968604A4 (en) | 2016-12-21 |
| EP2968604B1 (en) | 2018-02-28 |
| US20150209382A1 (en) | 2015-07-30 |
| CN105283205A (en) | 2016-01-27 |
| NZ711827A (en) | 2021-01-29 |
| JP2016515804A (en) | 2016-06-02 |
| AU2014229648A1 (en) | 2015-10-08 |
| US20140275223A1 (en) | 2014-09-18 |
| EP2968604A1 (en) | 2016-01-20 |
| WO2014140797A1 (en) | 2014-09-18 |
| ES2664759T3 (en) | 2018-04-23 |
| US9006200B2 (en) | 2015-04-14 |
| JP6437930B2 (en) | 2018-12-12 |
| IL241300B (en) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE057817T2 (en) | Anti-lag-3 antibodies to treat hematological malignancies | |
| HK1220155A1 (en) | Methods for treating cancer | |
| SG11201603050TA (en) | Methods for treating cancers | |
| PL3068854T5 (en) | Removal of unwanted propanol components | |
| GB201420103D0 (en) | Treating particles | |
| GB201312991D0 (en) | Process | |
| HK1213817A1 (en) | Methods of treating cancer | |
| GB201307334D0 (en) | Process | |
| GB201316269D0 (en) | Process | |
| PT3060689T (en) | Leaching of minerals | |
| HK1219513A1 (en) | Methods of treating cancer | |
| GB201313915D0 (en) | Process | |
| IL241300A0 (en) | Microrna-based approach to treating malignant pleural mesothelio | |
| PL3016682T3 (en) | Methods for treating cancer | |
| GB201314334D0 (en) | Process | |
| GB201302441D0 (en) | Process | |
| GB201322992D0 (en) | New Process | |
| GB201300073D0 (en) | Process | |
| EP2964773A4 (en) | Milling process | |
| GB201317756D0 (en) | New process | |
| GB201314561D0 (en) | Process | |
| GB201313211D0 (en) | New process | |
| GB201307951D0 (en) | Process | |
| GB201316253D0 (en) | Process | |
| GB201309182D0 (en) | Toucan filter process |